Our Halamid® Pharma production line has been EU GMP (ICHQ 7) inspected last April by SGS. The particularity of this audit was that it was organized by Axcentive but ordered by a group of customers that Axcentive brought together. For a GMP audit to be valid for the production of an Active Pharmaceutical Ingredient (API), the producer of the substance may not directly order this audit. The medicinal registration holders who buy the API are charged with this. The conclusion of SGS after the audit was positive and this is important for the continued validity of our customers’ registrations.